Man Group
BLFS icon

Man Group’s BioLife Solutions BLFS Stock Holding History

Man Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11M Buy
145,503
+72,877
+100% +$1.7M 0.01% 1236
2026
Q1 		$1.39M Buy
+72,626
New +$1.61M ﹤0.01% 1723
2025
Q3 		– Sell
-10,862
Closed -$234K – 2221
2025
Q2 		$234K Buy
+10,862
New +$245K ﹤0.01% 2030

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Man Group's BLFS Position: Q2 2026 in Review

Man Group increased its BioLife Solutions (BLFS) stake by 100% in Q2 2026, buying an estimated $1.7M and bringing the position to 145,503 shares worth $4.11M. The position accounts for 0.01% of the portfolio, ranked #1236.

Man Group first reported a position in BLFS in Q2 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Man Group held 145,503 shares of BioLife Solutions worth $4.11M as of Q2 2026.
  • Man Group bought 72,877 BioLife Solutions shares in Q2 2026, an estimated $1.7M.
  • BioLife Solutions made up 0.01% of Man Group's portfolio in Q2 2026, its #1236 holding.
  • Man Group first reported a position in BioLife Solutions in Q2 2025 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.